Background -An increase in pulmonary capillary blood volume secondary to angiogenesis has been described in Kaposi's sarcoma. The value of the pulmonary capillary blood volume as an early marker of pulmonary Kaposi's sarcoma was evaluated. Methods -In a prospective study 45 HIV positive patients (nine asymptomatic for Kaposi's sarcoma, 29 with cutaneous or mucocutaneous Kaposi's sarcoma, and seven with pulmonary Kaposi's sarcoma), underwent pulmonary function tests and determination of transfer capacity for carbon monoxide (TLCO) with its components, pulmonary capillary volume and membrane factor. Results -Total lung capacity (TLC), TLCO, and its components were similar in the three groups. TLCO was normal in patients with pulmonary Kaposi's sarcoma and no changes in membrane factor or pulmonary capillary volume were observed. Conclusion -Pulmonary function tests and pulmonary capillary volume alone are not useful for identifying patients with pulmonary Kaposi's sarcoma.
Pulmonary Kaposi's sarcoma is the most common non-infectious pulmonary manifestation of the acquired immunodeficiency syndrome (AIDS). Its frequency is uncertain because diagnosis requires histopathological proof. It has been estimated to occur in 20% but necropsies have shown pulmonary Kaposi's sarcoma in 55% of patients with AIDS and systemic Kaposi's sarcoma. ' Clinical symptomatology, chest radiographs, and computed tomographic (CT) scans are helpful for diagnosing pulmonary Kaposi's sarcoma but are not specific. Fibreoptic bronchoscopy remains the most sensitive technique available.
An increase in pulmonary capillary blood volume (Vc) has been measured in some patients with AIDS and cutaneous Kaposi's sarcoma including two who had probable pulmonary involvement.2 Histological studies have shown an increase in the number of capillary vessels in patients with pulmonary Kaposi's sarcoma suggestive of angiogenesis.3 Given the vascular nature of the tumour proliferation in Kaposi's sarcoma, we reasoned that even occult pulmonary localisations of Kaposi's sarcoma might cause an increase of Vc, irrespective of the overall value of transfer factor for carbon monoxide (TLCO).
It is important to diagnose pulmonary Kaposi's sarcoma early because it may respond to chemotherapy. The aim of this study was to evaluate TLCO and its components -that is, pulmonary capillary blood volume (Vc) and membrane factor (Dm) -as an early marker ofpulmonary Kaposi's sarcoma in HIV infected men.
Methods

PATIENTS
Forty five men from the H6pital Bichat-Claude Bernard infected with HIV were included in a prospective study between January and August 1993. The study was approved by the ethics committee of our institution and all the patients gave their written informed consent.
The following patients were not eligible for inclusion: intravenous drug abusers, patients with a history ofPneumocystis carinii pneumonia or with concomitant bronchopulmonary infection, and patients who had received more than 120 mg bleomycin.
The patients were divided into three groups. Control patients were divided into groups 1 and 2 according to the following criteria: group 1 -nine asymptomatic patients with HIV infection and no manifestation of Kaposi's sarcoma, and group 2 -29 patients with cutaneous Kaposi's sarcoma and no documented pulmonary involvement (normal chest radiograph, normal high resolution CT scan, and normal appearance at fibreoptic bronchoscopy). Group 3 consisted of seven patients with proven or probable pulmonary Kaposi's sarcoma on the basis of (1) 2 and 3. This may be related to smoking habits which were similar in the two groups. nodules with spindle-shaped outlines associated with peribronchial vascular thickening. The involvement of pulmonary Kaposi's sarcoma was depicted as 50% for maximal peribronchial vascular thickening, 25% for distal peribronchial vascular thickening, and 83% for nodules (unpublished data). The disease process of pulmonary Kaposi's sarcoma appeared to be both interstitial and interlobular.
Clinical features of pulmonary Kaposi's sarcoma may be not specific and could resemble those of pulmonary infection. In group 3 pulmonary capillary volume and membrane factor were slightly decreased. Murray et allo have reported a decrease in pulmonary capillary blood volume associated with a profound decrease in Kco and membrane factor in patients with AIDS and Pneumocystis carinii pneumonia. This infection was not involved in the deterioration of transfer factor parameters in our study as the BAL fluid was negative and both pulmonary capillary volume and membrane factor were only slightly decreased.
